drugset / Trial / NCT06287606

A Phase 3 Clinical Trials for Bowel Preparation for Colonoscopy

NCT06287606 ↗

Phase 3 Completed 161 enrolled Taejoon Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

A prospective randomized study compared to the active control. Researchers compare colon cleansing in patients undergoing colonoscopy

Timeline

Start
2023-08-29
Primary completion
2024-01-04
Completion
2024-01-04

Drugs

EvaluationDrugModalityDoseRoute
Subject CTP0302-A Unknown — —
Subject CTP0302-B Unknown — —

Indications

No indication recorded.